Bioburden Testing Market Key Findings by 2031
The bioburden testing market is anticipated to grow in the forecast period owing to key factors such as rise in the manufacturing of the medical devices and biopharmaceutical and pharmaceutical drugs. The rise in the expenditure for the healthcare industry are likely to robust the growth of the market. The increase in the CROs are likely to create growth opportunities in the forecast period.
The "Global Bioburden Testing Market Analysis to 2031" is a specialized and in-depth study of the biotechnology industry with a focus on the global market trend. The report aims to provide an overview of global bioburden testing market with detailed market segmentation by product, type of test, application, end user and geography. The global bioburden testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading bioburden testing market players and offers key trends and opportunities in the market.
The global bioburden testing market is segmented on the basis of product, type of test, application and end user. Based product, the market is segmented as instruments and consumables. Based on the type of test, the market is classified as anaerobic count test, aerobic count test, spore count test and mold count test. On the basis of application, the market is divided as medical device testing, in-process material testing, raw material testing and others. Based on the end user, the market is segmented as medical device manufacturers, pharmaceutical & biotechnology companies, contract manufacturing organizations and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global bioburden testing market based on product, type of test, application and end user. It also provides market size and forecast till 2031 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The bioburden testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.
North America is expected to contribute to the largest share in the bioburden testing market in the forecast period, due to the extensive manufacturing of the medical devices, innovative biopharmaceuticals and pharmaceutical products and others. Europe is expected to be second largest market and Asia Pacific is expected to be the fastest growing market owing to the rise in the manufacturing generic drugs and rise in the healthcare expenditure.
The report analyzes factors affecting bioburden testing market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the bioburden testing market in these regions.
The report also includes the profiles of key bioburden testing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the bioburden testing market include, Thermo Fisher Scientific Inc., Merck KGaA, bioMérieux SA, BD, QIAGEN, SGS SA, Pacific BioLabs, Nelson Laboratories, LLC, Charles River and STERIS.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1. Bioburden Testing Market- By Product
1.3.2. Bioburden Testing Market- By Type of Test
1.3.3. Bioburden Testing Market- By Application
1.3.4. Bioburden Testing Market- By End User
1.3.5. Bioburden Testing Market- By Region
1.3.5.1. By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BIOBURDEN TESTING MARKET LANDSCAPE
4.1. MARKET OVERVIEW
4.2. PEST ANALYSIS
4.2.1. North America - PEST Analysis
4.2.2. Europe - PEST Analysis
4.2.3. Asia Pacific - PEST Analysis
4.2.4. Middle East & Africa - PEST Analysis
4.2.5. South and Central America - PEST Analysis
5. BIOBURDEN TESTING MARKET- KEY INDUSTRY DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. BIOBURDEN TESTING MARKET- GLOBAL ANALYSIS
6.1. BIOBURDEN TESTING MARKET - GLOBAL MARKET OVERVIEW
6.2. BIOBURDEN TESTING MARKET - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/ MARKET SHARE OF KEY PLAYERS
7. BIOBURDEN TESTING MARKET REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. INSTRUMENTS MARKET
7.3.1. Overview
7.3.2. Instruments Market Forecast and Analysis (US$ Mn)
7.3.3. Microscopes Market
7.3.3.1. Overview
7.3.3.2. Microscopes Market Forecast and Analysis (US$ Mn)
7.3.1. PCR Market
7.3.1.1. Overview
7.3.1.2. PCR Market Forecast and Analysis (US$ Mn)
7.3.2. Automated Microbial Identification Systems Market
7.3.2.1. Overview
7.3.2.2. Automated Microbial Identification Systems Market Forecast and Analysis (US$ Mn)
7.3.3. Others Market
7.3.3.1. Overview
7.3.3.2. Others Market Forecast and Analysis (US$ Mn)
7.4. CONSUMABLES MARKET
7.4.1. Overview
7.4.2. Consumables Market Forecast and Analysis (US$ Mn)
7.4.3. Reagents & Kits Market
7.4.3.1. Overview
7.4.3.2. Reagents & Kits Market Forecast and Analysis (US$ Mn)
7.4.4. Medium Market
7.4.4.1. Overview
7.4.4.2. Medium Market Forecast and Analysis (US$ Mn)
7.4.5. Others Market
7.4.5.1. Overview
7.4.5.2. Others Market Forecast and Analysis (US$ Mn)
8. BIOBURDEN TESTING MARKET REVENUE AND FORECASTS TO 2028 - TYPE OF TEST
8.1. OVERVIEW
8.2. TYPE OF TEST MARKET FORECASTS AND ANALYSIS
8.3. ANAEROBIC COUNT TEST MARKET
8.3.1. Overview
8.3.2. Anaerobic Count Test Market Forecast and Analysis (US$ Mn)
8.4. AEROBIC COUNT TEST MARKET
8.4.1. Overview
8.4.2. Aerobic Count Test Market Forecast and Analysis (US$ Mn)
8.5. SPORE COUNT TEST MARKET
8.5.1. Overview
8.5.2. Spore Count Test Market Forecast and Analysis (US$ Mn)
8.6. MOLD COUNT TEST MARKET
8.6.1. Overview
8.6.2. Mold Count Test Market Forecast and Analysis (US$ Mn)
9. BIOBURDEN TESTING MARKET REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. MEDICAL DEVICE TESTING MARKET
9.3.1. Overview
9.3.2. Medical Device Testing Market Forecast and Analysis (US$ Mn)
9.4. IN-PROCESS MATERIAL TESTING MARKET
9.4.1. Overview
9.4.2. In-Process Material Testing Market Forecast and Analysis (US$ Mn)
9.5. RAW MATERIAL TESTING MARKET
9.5.1. Overview
9.5.2. Raw Material Testing Market Forecast and Analysis (US$ Mn)
9.6. OTHERS MARKET
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis (US$ Mn)
10. BIOBURDEN TESTING MARKET REVENUE AND FORECASTS TO 2028 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. MEDICAL DEVICE MANUFACTURERS MARKET
10.3.1. Overview
10.3.2. Medical Device Manufacturers Market Forecast and Analysis (US$ Mn)
10.4. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET
10.4.1. Overview
10.4.2. Pharmaceutical & Biotechnology Companies Market Forecast and Analysis (US$ Mn)
10.5. CONTRACT MANUFACTURING ORGANIZATIONS MARKET
10.5.1. Overview
10.5.2. Contract Manufacturing Organizations Market Forecast and Analysis (US$ Mn)
10.6. OTHERS MARKET
10.6.1. Overview
10.6.2. Others Market Forecast and Analysis (US$ Mn)
11. BIOBURDEN TESTING MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA BIOBURDEN TESTING MARKET
11.1.1. North America Bioburden Testing Market Forecasts and Analysis (US$ Mn)
11.1.2. North America Bioburden Testing Market Forecasts and Analysis - By Product (US$ Mn)
11.1.2.1. North America Instruments Market Forecasts and Analysis - By Type(US$ Mn)
11.1.2.2. North America Consumables Market Forecasts and Analysis - By Type(US$ Mn)
11.1.3. North America Bioburden Testing Market Forecasts and Analysis - By Type of Test (US$ Mn)
11.1.4. North America Bioburden Testing Market Forecasts and Analysis - By Application (US$ Mn)
11.1.1. North America Bioburden Testing Market Forecasts and Analysis - By End User (US$ Mn)
11.1.2. North America Bioburden Testing Market Forecasts and Analysis - By Country
11.1.3. US Market Overview
11.1.3.1. US Bioburden Testing Market Forecasts and Analysis - By Product (US$ Mn)
11.1.3.1.1. US Instruments Market Forecasts and Analysis - By Type(US$ Mn)
11.1.3.1.2. US Consumables Market Forecasts and Analysis - By Type(US$ Mn)
11.1.3.2. US Bioburden Testing Market Forecasts and Analysis - By Type of Test (US$ Mn)
11.1.3.3. US Bioburden Testing Market Forecasts and Analysis - By Application (US$ Mn)
11.1.3.4. US Bioburden Testing Market Forecasts and Analysis - By End User (US$ Mn)
11.1.4. Canada Market Overview
11.1.4.1. Canada Bioburden Testing Market Forecasts and Analysis - By Product (US$ Mn)
11.1.4.1.1. Canada Instruments Market Forecasts and Analysis - By Type(US$ Mn)
11.1.4.1.2. Canada Consumables Market Forecasts and Analysis - By Type(US$ Mn)
11.1.4.2. Canada Bioburden Testing Market Forecasts and Analysis - By Type of Test (US$ Mn)
11.1.4.3. Canada Bioburden Testing Market Forecasts and Analysis - By Application (US$ Mn)
11.1.4.4. Canada Bioburden Testing Market Forecasts and Analysis - By End User (US$ Mn)
11.1.5. Mexico Market Overview
11.1.5.1. Mexico Bioburden Testing Market Forecasts and Analysis - By Product (US$ Mn)
11.1.5.1.1. Mexico Instruments Market Forecasts and Analysis - By Type(US$ Mn)
11.1.5.1.2. Mexico Consumables Market Forecasts and Analysis - By Type(US$ Mn)
11.1.5.2. Mexico Bioburden Testing Market Forecasts and Analysis - By Type of Test (US$ Mn)
11.1.5.3. Mexico Bioburden Testing Market Forecasts and Analysis - By Application (US$ Mn)
11.1.5.4. Mexico Bioburden Testing Market Forecasts and Analysis - By End User (US$ Mn)
11.2. EUROPE BIOBURDEN TESTING MARKET
11.2.1. Europe Bioburden Testing Market Forecasts and Analysis (US$ Mn)
11.2.2. Europe Bioburden Testing Market Forecasts and Analysis - By Product (US$ Mn)
11.2.2.1. Europe Instruments Market Forecasts and Analysis - By Type(US$ Mn)
11.2.2.2. Europe Consumables Market Forecasts and Analysis - By Type(US$ Mn)
11.2.3. Europe Bioburden Testing Market Forecasts and Analysis - By Type of Test (US$ Mn)
11.2.4. Europe Bioburden Testing Market Forecasts and Analysis - By Application (US$ Mn)
11.2.5. Europe Bioburden Testing Market Forecasts and Analysis - By End User (US$ Mn)
11.2.6. Europe Bioburden Testing Market Forecasts and Analysis - By Country
11.2.7. UK Market Overview
11.2.7.1. UK Bioburden Testing Market Forecasts and Analysis - By Product (US$ Mn)
11.2.7.1.1. UK Instruments Market Forecasts and Analysis - By Type(US$ Mn)
11.2.7.1.2. UK Consumables Market Forecasts and Analysis - By Type(US$ Mn)
11.2.7.2. UK Bioburden Testing Market Forecasts and Analysis - By Type of Test (US$ Mn)
11.2.7.3. UK Bioburden Testing Market Forecasts and Analysis - By Application (US$ Mn)
11.2.7.4. UK Bioburden Testing Market Forecasts and Analysis - By End User (US$ Mn)
11.2.8. Germany Market Overview
11.2.8.1. Germany Bioburden Testing Market Forecasts and Analysis - By Product (US$ Mn)
11.2.8.1.1. Germany Instruments Market Forecasts and Analysis - By Type(US$ Mn)
11.2.8.1.2. Germany Consumables Market Forecasts and Analysis - By Type(US$ Mn)
11.2.8.2. Germany Bioburden Testing Market Forecasts and Analysis - By Type of Test (US$ Mn)
11.2.8.3. Germany Bioburden Testing Market Forecasts and Analysis - By Application (US$ Mn)
11.2.8.4. Germany Bioburden Testing Market Forecasts and Analysis - By End User (US$ Mn)
11.2.9. France Market Overview
11.2.9.1. France Bioburden Testing Market Forecasts and Analysis - By Product (US$ Mn)
11.2.9.1.1. France Instruments Market Forecasts and Analysis - By Type(US$ Mn)
11.2.9.1.2. France Consumables Market Forecasts and Analysis - By Type(US$ Mn)
11.2.9.2. France Bioburden Testing Market Forecasts and Analysis - By Type of Test (US$ Mn)
11.2.9.3. France Bioburden Testing Market Forecasts and Analysis - By Application (US$ Mn)
11.2.9.4. France Bioburden Testing Market Forecasts and Analysis - By End User (US$ Mn)
11.3. ASIA PACIFIC BIOBURDEN TESTING MARKET
11.3.1. Asia Pacific Bioburden Testing Market Forecasts and Analysis (US$ Mn)
11.3.2. Asia Pacific Bioburden Testing Market Forecasts and Analysis - By Product (US$ Mn)
11.3.2.1. Asia Pacific Instruments Market Forecasts and Analysis - By Type(US$ Mn)
11.3.2.2. Asia Pacific Consumables Market Forecasts and Analysis - By Type(US$ Mn)
11.3.3. Asia Pacific Bioburden Testing Market Forecasts and Analysis - By Type of Test (US$ Mn)
11.3.4. Asia Pacific Bioburden Testing Market Forecasts and Analysis - By Application (US$ Mn)
11.3.5. Asia Pacific Bioburden Testing Market Forecasts and Analysis - By End User (US$ Mn)
11.3.6. Asia Pacific Bioburden Testing Market Forecasts and Analysis - By Country
11.3.7. China Market Overview
11.3.7.1. China Bioburden Testing Market Forecasts and Analysis - By Product (US$ Mn)
11.3.7.1.1. China Instruments Market Forecasts and Analysis - By Type(US$ Mn)
11.3.7.1.2. China Consumables Market Forecasts and Analysis - By Type(US$ Mn)
11.3.7.2. China Bioburden Testing Market Forecasts and Analysis - By Type of Test (US$ Mn)
11.3.7.3. China Bioburden Testing Market Forecasts and Analysis - By Application (US$ Mn)
11.3.7.4. China Bioburden Testing Market Forecasts and Analysis - By End User (US$ Mn)
11.3.8. Japan Market Overview
11.3.8.1. Japan Bioburden Testing Market Forecasts and Analysis - By Product (US$ Mn)
11.3.8.1.1. Japan Instruments Market Forecasts and Analysis - By Type(US$ Mn)
11.3.8.1.2. Japan Consumables Market Forecasts and Analysis - By Type(US$ Mn)
11.3.8.2. Japan Bioburden Testing Market Forecasts and Analysis - By Type of Test (US$ Mn)
11.3.8.3. Japan Bioburden Testing Market Forecasts and Analysis - By Application (US$ Mn)
11.3.8.4. Japan Bioburden Testing Market Forecasts and Analysis - By End User (US$ Mn)
11.3.9. India Market Overview
11.3.9.1. India Bioburden Testing Market Forecasts and Analysis - By Product (US$ Mn)
11.3.9.1.1. India Instruments Market Forecasts and Analysis - By Type(US$ Mn)
11.3.9.1.2. India Consumables Market Forecasts and Analysis - By Type(US$ Mn)
11.3.9.2. India Bioburden Testing Market Forecasts and Analysis - By Type of Test (US$ Mn)
11.3.9.3. India Bioburden Testing Market Forecasts and Analysis - By Application (US$ Mn)
11.3.9.4. India Bioburden Testing Market Forecasts and Analysis - By End User (US$ Mn)
11.4. MIDDLE EAST & AFRICA BIOBURDEN TESTING MARKET
11.4.1. Middle East & Africa Bioburden Testing Market Forecasts and Analysis (US$ Mn)
11.4.2. Middle East & Africa Bioburden Testing Market Forecasts and Analysis - By Product (US$ Mn)
11.4.2.1. Middle East & Africa Instruments Market Forecasts and Analysis - By Type(US$ Mn)
11.4.2.2. Middle East & Africa Consumables Market Forecasts and Analysis - By Type(US$ Mn)
11.4.3. Middle East & Africa Bioburden Testing Market Forecasts and Analysis - By Type of Test (US$ Mn)
11.4.4. Middle East & Africa Bioburden Testing Market Forecasts and Analysis - By Application (US$ Mn)
11.4.5. Middle East & Africa Bioburden Testing Market Forecasts and Analysis - By End User (US$ Mn)
11.4.6. Middle East & Africa Bioburden Testing Market Forecasts and Analysis - By Country
11.4.7. UAE Market Overview
11.4.7.1. UAE Bioburden Testing Market Forecasts and Analysis - By Product (US$ Mn)
11.4.7.1.1. UAE Instruments Market Forecasts and Analysis - By Type(US$ Mn)
11.4.7.1.2. UAE Consumables Market Forecasts and Analysis - By Type(US$ Mn)
11.4.7.2. UAE Bioburden Testing Market Forecasts and Analysis - By Type of Test (US$ Mn)
11.4.7.3. UAE Bioburden Testing Market Forecasts and Analysis - By Application (US$ Mn)
11.4.7.4. UAE Bioburden Testing Market Forecasts and Analysis - By End User (US$ Mn)
11.4.8. Saudi Arabia Market Overview
11.4.8.1. Saudi Arabia Bioburden Testing Market Forecasts and Analysis - By Product (US$ Mn)
11.4.8.1.1. Saudi Arabia Instruments Market Forecasts and Analysis - By Type(US$ Mn)
11.4.8.1.2. Saudi Arabia Consumables Market Forecasts and Analysis - By Type(US$ Mn)
11.4.8.2. Saudi Arabia Bioburden Testing Market Forecasts and Analysis - By Type of Test (US$ Mn)
11.4.8.3. Saudi Arabia Bioburden Testing Market Forecasts and Analysis - By Application (US$ Mn)
11.4.8.4. Saudi Arabia Bioburden Testing Market Forecasts and Analysis - By End User (US$ Mn)
11.4.9. South Africa Market Overview
11.4.9.1. South Africa Bioburden Testing Market Forecasts and Analysis - By Product (US$ Mn)
11.4.9.1.1. South Africa Instruments Market Forecasts and Analysis - By Type(US$ Mn)
11.4.9.1.2. South Africa Consumables Market Forecasts and Analysis - By Type(US$ Mn)
11.4.9.2. South Africa Bioburden Testing Market Forecasts and Analysis - By Type of Test (US$ Mn)
11.4.9.3. South Africa Bioburden Testing Market Forecasts and Analysis - By Application (US$ Mn)
11.4.9.4. South Africa Bioburden Testing Market Forecasts and Analysis - By End User (US$ Mn)
11.5. SOUTH AND CENTRAL AMERICA BIOBURDEN TESTING MARKET
11.5.1. South And Central America Bioburden Testing Market Forecasts and Analysis (US$ Mn)
11.5.2. South And Central America Bioburden Testing Market Forecasts and Analysis - By Product (US$ Mn)
11.5.2.1. South And Central America Instruments Market Forecasts and Analysis - By Type(US$ Mn)
11.5.2.2. South And Central America Consumables Market Forecasts and Analysis - By Type(US$ Mn)
11.5.3. South And Central America Bioburden Testing Market Forecasts and Analysis - By Type of Test (US$ Mn)
11.5.4. South And Central America Bioburden Testing Market Forecasts and Analysis - By Application (US$ Mn)
11.5.5. South And Central America Bioburden Testing Market Forecasts and Analysis - By End User (US$ Mn)
11.5.6. South And Central America Bioburden Testing Market Forecasts and Analysis - By Country
11.5.7. Brazil Market Overview
11.5.7.1. Brazil Bioburden Testing Market Forecasts and Analysis - By Product (US$ Mn)
11.5.7.1.1. Brazil Instruments Market Forecasts and Analysis - By Type(US$ Mn)
11.5.7.1.2. Brazil Consumables Market Forecasts and Analysis - By Type(US$ Mn)
11.5.7.2. Brazil Bioburden Testing Market Forecasts and Analysis - By Type of Test (US$ Mn)
11.5.7.3. Brazil Bioburden Testing Market Forecasts and Analysis - By Application (US$ Mn)
11.5.7.4. Brazil Bioburden Testing Market Forecasts and Analysis - By End User (US$ Mn)
12. INDUSTRY LANDSCAPE
12.1. ORGANIC GROWTH STRATEGIES
12.1.1. New Product Launches
12.1.2. Marketing & Promotional Activities
12.2. INORGANIC GROWTH STRATEGIES
12.2.1. Partnerships, Collaborations, and Joint Ventures
12.2.2. Mergers & Acquisitions
13. BIOBURDEN TESTING MARKET, KEY COMPANY PROFILES
13.1. THERMO FISHER SCIENTIFIC INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Financial Overview
13.1.4. Product Portfolio
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. MERCK KGAA
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Financial Overview
13.2.4. Product Portfolio
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BIOMERIEUX SA
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Financial Overview
13.3.4. Product Portfolio
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. BD
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Financial Overview
13.4.4. Product Portfolio
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. QIAGEN
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Financial Overview
13.5.4. Product Portfolio
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. SGS SA
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Financial Overview
13.6.4. Product Portfolio
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. PACIFIC BIOLABS
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Financial Overview
13.7.4. Product Portfolio
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. NELSON LABORATORIES, LLC
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Financial Overview
13.8.4. Product Portfolio
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. CHARLES RIVER
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Financial Overview
13.9.4. Product Portfolio
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. STERIS
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Financial Overview
13.10.4. Product Portfolio
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. Thermo Fisher Scientific Inc.
2. Merck KGaA
3. bioMérieux SA
4. BD
5. QIAGEN
6. SGS SA
7. Pacific BioLabs
8. Nelson Laboratories, LLC
9. Charles River
10. STERIS
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.